Please contact us by using the Inquiry Form. We will ask for more details by e-mail, so just a brief description is sufficient. You can also contact us from the page that appears by clicking on the structural formula.
SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
---|---|---|---|---|---|
04706 | N3-PEG13-COOMe | 73,500/2.5mg | >95% | 2.6 | |
06024 | CONHS-PEG12-OCONHS | 93,000/7.5mg | >90% | 128.1 | |
06457 | Cyclic(-PEG4-N-)-CO-PEG11-COOH | 71,500/0.1mg | >95% | 13.3 | |
04666 | Bisphenol-A decacarbonate | 68,800/0.1mg | >95% | 3.2 | |
02768 | COOtBu-PEG11-COOH | 66,500/25mg | >95% | 0 | |
04665 | Bisphenol-A nonacarbonate | 68,800/0.1mg | >95% | 4.8 | |
06023 | CONHS-PEG9-OCONHS | 93,000/7.5mg | >90% | 0 | |
04664 | Bisphenol-A octacarbonate | 68,800/0.1mg | >95% | 6.8 | |
06874 | COOtBu-PEG8-COOH | 68,900/7.5mg | >95% | 0 | |
04663 | Bisphenol-A heptacarbonate | 68,800/0.1mg | >95% | 9.9 | |
06873 | COOtBu-PEG7-COOH | 68,900/7.5mg | >95% | 0 | |
05695 | Bis-DBCO of diaminoPEG7 | 64,000/0.7mg | >95% | 103.1 | |
04662 | Bisphenol-A hexacarbonate | 68,800/0.1mg | >95% | 12.2 | |
06870 | COOMe-PEG6-COOH | 63,800/100mg | >95% | 0 | |
04819 | COOtBu-PEG6-COOH | 66,500/100mg | >95% | 8.7 | |
04661 | Bisphenol-A pentacarbonate | 65,700/0.4mg | >95% | 12.7 | |
06872 | COOtBu-PEG5-COOH | 66,500/100mg | >95% | 0 | |
06022 | CONHS-PEG5-OCONHS | 97,000/5mg | >90% | 0 | |
05588 | Bis-DBCO of diaminoPEG5 | 64,600/0.5mg | >95% | 28.3 | |
04660 | Bisphenol-A tetracarbonate | 63,400/0.1mg | >95% | 10.4 | |
02773 | COOMe-PEG5-COOH | 66,500/100mg | >95% | 423.0 | |
06012 | CONHS-PEG4-OCONHS | 100,500/25mg | >90% | 180.6 | |
04659 | Bisphenol-A tricarbonate | 68,800/0.2mg | >95% | 17.1 | |
04313 | Piv-PEG4-OPiv | 70,800/750mg | >95% | 0 | |
02216 | COOtBu-PEG4-COOH | inquire | >95% | 0 | |
06871 | COOtBu-PEG3-COOH | inquire | >95% | 0 | |
04658 | bis-Bisphenol-A dicarbonate | 65,700/0.4mg | >95% | 7.4 | |
04071 | Me-PEG3-OCOCBrMe2 | 66,100/50mg | >95% | 111.8 | |
03603 | Trt-PEG3-(OCO-PEG3)2-OTrt | 70,800/2.5mg | >95% | 0.4 | |
03602 | Trt-PEG3-(OCO-PEG3)3-OTrt | 70,800/2.5mg | >95% | 2.9 | |
03597 | Trt-PEG3-OCO-PEG3-COO-PEG3-OTrt | 64,000/5mg | >95% | 130.8 | |
03549 | Cyclic(-PEG3-OCO-)4 | 66,700/0.7mg | >80% | 135.6 | |
03548 | Cyclic(-PEG3-OCO-)3 | 71,500/5mg | >80% | 37.1 | |
03547 | Cyclic(-PEG3-OCO-)2 | 71,500/5mg | >80% | 67.2 | |
03546 | Cyclic(-PEG3-OCO-) | 68,400/0.4mg | >80% | 7.6 | |
03512 | Trt-PEG3-OCO-PEG3-OTrt | 70,800/2.5mg | >95% | 75.3 | |
02426 | OH-PEG3-OCO-PEG3-OH | 68,900/250mg | >95% | 2,000.0 | |
01931 | Trt-PEG3-OCOSu | 64,900/75mg | >95% | 1,400.0 | |
01930 | p-NPOC-PEG3-Methacrylate | 68,800/5mg | >90% | 1,000.0 | |
01196 | Trt-PEG3-PNPOC | 70,800/2.5mg | >95% | 2,980.0 | |
04657 | Bisphenol-A monocarbonate | 64,000/0.7mg | >95% | 18.6 | |
03637 | Trt-BisphenolA-OCO-BisphanolA | 68,800/0.1mg | >95% | 0.1 | |
06027 | CONHS-PEG2K-OCONHS | 97,000/5mg | <80% | 0 | |
06026 | CONHS-PEG1.4K-OCONHS | 94,400/5mg | <80% | 0 | |
06025 | CONHS-PEG1K-OCONHS | 96,000/7.5mg | <80% | 30.8 | |
08734 | [(Z)-1-methylsulfonylethylideneamino] N-methylcarbamate | 50,000/1mg | >95% | 0.7 | |
07517 | Dichloroprop methyl ester D3 | 66,300/2.5mg | >95% | 0 | |
07516 | 2,4-DB methyl ester D3 | 66,300/2.5mg | >95% | 0 | |
07508 | Mecoprop methylester | inquire | >95% | 10.0 | |
06896 | 2,4,5-Triphenol glucuronide Methylester triacetate | 68,800/5mg | >90% | 42.0 | |
06852 | 2,4-DB methyl ester | inquire | >95% | 0 | |
06851 | Dichloroprop methyl ester | inquire | >95% | 138.1 | |
06849 | 2,4-PA-methylester-d5 | 65,000/5mg | >95% | 0 | |
06847 | 2,4-PA-methylester | 5,000/100mg | >95% | 106.4 | |
06818 | 5-acetylpyrrolidin-2-one | 68,800/5mg | >95% | 111.1 | |
06814 | 1,5-diacetylpyrrolidin-2-one | 64,900/7.5mg | >95% | 28,414.0 | |
06633 | Phenthoate oxon | 68,800/5mg | >95% | 140.9 | |
06607 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | 66,300/5mg | >95% | 0.2 | |
06108 | Mono-6-(NHS-C4-amide)-beta-cyclodextrin | 72,300/2.5mg | >80% | 18.0 | |
06107 | Mono-6-(NHS-C4-amide)-alpha-cyclodextrin | 72,300/2.5mg | >80% | 14.0 | |
06102 | Mono-6-(COOH-C4-NH)-beta-cyclodextrin | 68,800/5mg | >80% | 92.1 | |
06101 | Mono-6-(COOH-C4-NH)-alpha-cyclodextrin | 68,800/5mg | >80% | 102.7 | |
05979 | 5-ethoxy-5-oxohexyl triphenyl Phosphonium bromide | 63,400/100mg | >90% | 2,056.4 | |
05939 | 5-cyanovaleramide | 64,900/75mg | >90% | 230.0 | |
05915 | (E)-4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxo-but-2-enoic acid | 68,800/0.1mg | >95% | 26.0 | |
05914 | N,N'-bis(2,5-dimethylpyrrol-1-yl)oxamide | inquire | >95% | 536.2 | |
05873 | N-[2-(2,5-dioxopyrrolidin-1-yl)-3-isobutoxy-propyl]-N-phenyl-benzamide | 68,800/0.2mg | >95% | 0.2 | |
05872 | N-(2-hydroxy-3-isobutoxy-propyl)-N-phenyl-benzamide | 72,300/2.5mg | >95% | 126.1 | |
05863 | MOiDP | 65,700/0.4mg | >95% | 0 | |
05856 | 2-((3-(benzyloxy)-3-oxopropoxy)carbonyl)benzoic-3,4,5,6-d4 acid | 68,800/0.1mg | >95% | 86.0 | |
05854 | 2-((3-(benzyloxy)-3-oxopropoxy)carbonyl)benzoic acid | 64,000/0.7mg | >95% | 92.0 | |
05846 | Doxycycline N-monodesmethyl | 64,000/0.7mg | >95% | 38.3 | |
05835 | 2,4-Dichlorophenol glucuronide Methylester triacetate | 30,000/5mg | >90% | 35.3 | |
05803 | N-demethyl-N-propargyl oxytetracycline | 76,000/0.1mg | >95% | 1.0 | |
05798 | ethyl 4-(N-methylanilino)butanoate | 70,900/500mg | >95% | 4,398.8 | |
05788 | isobutyl 2,4-dichlorophenoxycarbonate | 64,900/75mg | >95% | 2,240.0 | |
05777 | Milbemectin A4 | 64,900/7.5mg | >95% | 114.7 | |
05775 | 3,5-Di-tert-butyl-4-hydroxyphenylpropionicAcid monoethoxylate | 64,000/5mg | >95% | 385.0 | |
05768 | Cyclosporin AM-1 | 76,000/0.1mg | >95% | 49.5 | |
05765 | benzyl 2-(N-methylanilino)acetate | 72,300/25mg | >95% | 1,940.0 | |
05677 | Benzyl alpha,beta-D-glucuronate | 68,100/750mg | >90% | 1,728.0 | |
05673 | Allyl 2,3,4-tri-O-acetyl-alpha-D-glucopyranosyluronate bromide | 68,800/5mg | >90% | 350.0 | |
05672 | 1,2,3,4-Tetra-O-acetyl-beta-D-glucuronic acid allyl ester | 63,400/5mg | >90% | 60.0 | |
05670 | 2-(1-adamantyl-N-2,6-dimethylphenyl)-acetamide | 64,000/0.7mg | >95% | 84.7 | |
05621 | Acetobromo-alpha-D-glucuronic acid methyl ester | 12,000/1,000mg | >90% | 13,081.4 | |
05612 | N-(2,6-dimethylphenyl)-N-(hydroxyacetyl)alanine methyl ester | 63,400/0.2mg | >90% | 149.0 | |
05609 | N-(2,6-Dimethylphenyl)-N-(methoxyacetyl)-DL-alanine methyl ester | inquire | >90% | 573.0 | |
05603 | methyl 2-(N-2,6-dimethylphenyl)aminopropionate | 68,800/5mg | >95% | 10.0 | |
05568 | Acetamide, N-(3,6,8-tribromo-1-pyrenyl)- | 64,900/7.5mg | >95% | 277.6 | |
05567 | 1-acetylaminopyrene | 64,600/0.5mg | >95% | 55.0 | |
05506 | 2-propenoic acid, 2-methyl-3-nitro-, methy ester | 64,600/0.5mg | >95% | 313.2 | |
05425 | Pilsicainide.HCl D6 | 76,000/0.1mg | >95% | 64.0 | |
05391 | (2,3-dihydroxy-1-methoxycarbonyl-propyl) 2,2-dimethylpropanoate | 64,000/5mg | >90% | 252.6 | |
05390 | [1-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-methoxy-2-oxo-ethyl] 2,2-dimethylpropanoate | 69,300/250mg | >95% | 2,031.0 | |
05374 | 2-[[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]amino]-2-oxo-acetic acid | 64,000/5mg | >95% | 73.3 | |
05372 | N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]-2-hydroxy-acetamide | 70,000/25mg | >95% | 82.4 | |
05231 | Propyl 2-[3-oxo-2-(2-oxoethyl)cyclopentyl]acetate | 63,400/50mg | >95% | 2,144.4 | |
05227 | propyl 2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetate | 69,300/250mg | >95% | 18,602.0 | |
05175 | (3,4-dimethoxy-4-oxo-butyl)-trimethyl-ammonium | 64,000/5mg | >90% | 32.5 | |
05052 | Carbaryl-D7 | 55,000/20mg | >95% | 0 | |
05047 | Isoprothiolane-D4 | 55,000/20mg | >95% | 0 | |
05033 | Ampicillin-D5 | 77,000/10mg | >95% | 0 | |
05030 | Mono-n-butyl phthalate | 60,000/20mg | >95% | 0 | |
04813 | Mono-6-(COOH-C3-CO-NH)-beta-cyclodextrin | 64,000/0.7mg | >95% | 17.8 | |
04282 | Mono TSE succinic acid | 63,400/50mg | >95% | 1,400.0 | |
04234 | 2-imino-1,5-dimethyl-imidazolidin-4-one | 64,000/5mg | >95% | 554.0 | |
04151 | Heat Shock Protein Inhibitor II | 68,100/0.2mg | >95% | 7.3 | |
04140 | ethyl 7,7-dicyanoheptanoate | 82,300/2.5mg | >95% | 0.1 | |
04049 | (3-azido-2-hydroxy-1-methoxycarbonyl-propyl) 2,2-dimethylpropanoate | 64,000/5mg | >90% | 37.3 | |
03616 | Naphthalene-2-carboxylic acid ethyl ester | inquire | >95% | 13,450.0 | |
03606 | ethyl 2-(5-ethoxycarbonyl)pentyl-2-methylacetoacetate | 70,800/2.5mg | >95% | 7.4 | |
03541 | Mono-6-O-tBu-acetate-beta-cyclodextrine mixture of isomers | 68,900/2.5mg | >95% | 439.8 | |
03505 | Glycerol(Trt)(Palmitoyl)[Palmitoyl} | 63,400/50mg | >95% | 54.6 | |
03486 | Glycerol(Trt)(DMT)[linolate] | 64,000/5mg | >95% | 8.8 | |
03485 | Glycerol(Trt)(Pal)[OH] | 63,400/50mg | >95% | 93.9 | |
02732 | [3-azido-5-(9H-fluoren-9-ylmethoxycarbonylamino)phenyl]methyl (4-nitrophenyl) carbonate | 65,700/0.4mg | >95% | 0 | |
02705 | L-Glu(Me)-OMe.HCl | inquire | >95% | 730.0 | |
02646 | 5-Hydroxypentanoic Acid Methyl Ester | 63,400/50mg | >95% | 3,000.0 | |
02622 | N-benzyl trichloroacetamide | 72,300/2.5mg | >95% | 0 | |
02337 | (4-nitrophenyl) vinyl carbonate | 80,900/75mg | >95% | 137.0 | |
01964 | 1-(2-amino-2-oxo-ethyl)pyridin-1-ium-3-carboxamide | 69,300/250mg | >95% | 2,050.0 | |
01856 | Methyl 2-iodoacetate | 66,300/25mg | >95% | 1,000.0 | |
01853 | N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide | 64,000/5mg | >95% | 246.0 | |
01708 | [4-(3,4-Difluorobenzoyl)oxyphenyl] 3,4-difluorobenzoate | 64,600/0.5mg | >80% | 145.0 | |
01446 | Methylazoxymethanol acetate | 45,000/20mg | >95% | 6,800.0 | |
01401 | Octanediamide | 68,400/0.4mg | >95% | 1.0 | |
01358 | 3-(2,2,2-trifluoro-acetyl)-dihydro-furan-2-one | 67,900/750mg | >95% | 7,890.1 | |
00742 | 8-Ethoxy-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid ethyl ester | 72,300/500mg | >95% | 8,200.1 | |
00684 | 3-(3,4-Dihydroxy-phenyl)-acrylic acid ethyl ester | inquire | >95% | 10.0 | |
00683 | 3-(3,4-Bis-benzyloxy-phenyl)-acrylic acid ethyl ester | 64,600/0.5mg | >95% | 20.0 | |
00651 | 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide-d4 | 68,000/10mg | >95% | 817.0 | |
00413 | 1H-Imidazolium, 1,2-dimethyl-3-[(2,2,2-trichloroethoxy)sulfonyl]-, 1,1,1-trifluoromethanesulfonate | 70,000/25mg | >95% | 466.0 | |
00384 | 8-Chloro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid ethyl ester | 63,400/50mg | >95% | 1,960.0 | |
00352 | 2,2,2-Trichloroethyl chlorosulfate | inquire | <80% | 2,521.7 | |
00279 | methyl 3-bis(3-methoxy-3-oxo-propyl)phosphanylpropanoate | 72,300/25mg | >90% | 181.4 | |
00180 | N-(2,4-Dichloro-phenyl)-malonamic acid ethyl ester | 70,000/25mg | >90% | 3,320.1 | |
00177 | tribromoacetamide | 64,600/0.5mg | >95% | 0 |